Key Trends Influencing the Growth of the Plasma Protein Therapeutics Market in 2025: Innovative Products Drive Competition In The Plasma Protein Therapeutics Market

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Plasma Protein Therapeutics Market Through 2025?
Over the past few years, the plasma protein therapeutics market has observed a robust growth. It is projected to rise from $31.86 billion in 2024 to $34.55 billion in 2025, at a compound annual growth rate (CAGR) of 8.5%. The historic period's growth can be credited to a rise in rare diseases, an aging population, an increase in the worldwide supply of blood plasma, a surge in hemophilia cases, advancements in diagnostic procedures, and a conducive regulatory landscape.

What's the Projected Size of the Global Plasma Protein Therapeutics Market by 2029?
Anticipated to witness significant expansion in the upcoming years, the plasma protein therapeutics market is projected to surge to a value of $46.35 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. This growth within the forecast period can be credited to advancements in gene therapy, incremented healthcare spending, broader indications, precision medicine methods, and patient access programs. Notable trends during the forecast period comprise of novel technological developments, growing utilization of telemedicine, enhancements in plasma fractionation technology, emergence of new-generation therapies, integration of recombinant therapies, and personalized medicine methodologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Top Growth Drivers in the Plasma Protein Therapeutics Industry: What's Accelerating the Market?
The escalating occurrence of autoimmune disorders is anticipated to push forward the growth of the plasma protein therapeutics market. An autoimmune disorder happens when the body's immune system mistakenly destroys healthy cells. Plasma protein therapeutics, through therapeutic plasma exchange, are used to treat these autoimmune diseases, which arise when the body incorrectly identifies a part of itself as foreign and generates proteins (autoantibodies) that target that improperly recognized part. For example, a study from the University of Glasgow, a public university based in the UK, engaged 22 million people in May 2023 and discovered that about 10% of the UK's population suffers from autoimmune disorders. This number is higher than previously anticipated. Thus, the growing occurrence of autoimmune disorders boosts forward the expansion of the plasma protein therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

What Trends Will Shape the Plasma Protein Therapeutics Market Through 2029 and Beyond?
The escalation of product innovations is becoming a significant trend in the plasma protein therapeutic market. Key players in this sector concentrate on pioneering developments to secure a leading edge in the industry. For example, Octapharma AG, a company originating from Switzerland, received approbation from European medical authorities for its lyophilized variation of the acclaimed product, octaplasLG, in October 2023. The new formulation is contrived for pre-hospital transfusions, thus aiding healthcare professionals with a practical and potent solution for administering patient care in critical scenarios. The green light marks Octapharma's pledge to improving patient care by leveraging novel advancements in the domain of blood products.

What Are the Main Segments in the Plasma Protein Therapeutics Market?
The plasma protein therapeutics market covered in this report is segmented -

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Subsegments:
1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Albumin: Human Serum Albumin, Recombinant Albumin
3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates
4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors
5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9213&type=smp

Which Top Companies are Driving Growth in the Plasma Protein Therapeutics Market?
Major companies operating in the plasma protein therapeutics market include CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., New York Blood Center, Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Australian Red Cross Lifeblood

Which Regions Will Dominate the Plasma Protein Therapeutics Market Through 2029?
North America was the largest region in the plasma protein therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9213

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.